Pharmacological inhibition from the ataxia telangiectasia and Rad3-connected protein serine/threonine kinase (ATR; often called FRAP-relevant protein (FRP1)) has emerged being a promising system for cancer treatment that exploits artificial lethal interactions with proteins associated with DNA damage repair service, overcomes resistance to other therapies and enhances antitumour immun... https://ericr888dox9.wikikali.com/user